Women’s Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions

Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortality risks among women with hormone-sensitive breast cancer. However, adherence to AET is suboptimal. To guide the development of theory-based interventions to enhance AET adherence, we conducted a stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphries, Brittany, Collins, Stéphanie, Guillaumie, Laurence, Lemieux, Julie, Dionne, Anne, Provencher, Louise, Moisan, Jocelyne, Lauzier, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024955/
https://www.ncbi.nlm.nih.gov/pubmed/29890738
http://dx.doi.org/10.3390/pharmacy6020053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024955/
https://www.ncbi.nlm.nih.gov/pubmed/29890738
http://dx.doi.org/10.3390/pharmacy6020053

Ejemplares similares